Roivant and Pfizer's Treatment Demonstrates 'Patient-Focused Advantages' for Uncommon Inflammatory Disorder

Roivant and Pfizer’s Treatment Demonstrates ‘Patient-Focused Advantages’ for Uncommon Inflammatory Disorder

Roivant and Pfizer's Treatment Demonstrates 'Patient-Focused Advantages' for Uncommon Inflammatory Disorder